Literature DB >> 29272502

Staphylococcus aureus SaeR/S-Regulated Factors Decrease Monocyte-Derived Tumor Necrosis Factor-α to Reduce Neutrophil Bactericidal Activity.

Eli W Sward1, Elizabeth M Fones1, Russel R Spaan1, Kyler B Pallister1, Brandon L Haller1, Fermin E Guerra1, Oliwia W Zurek2, Tyler K Nygaard1, Jovanka M Voyich1.   

Abstract

Background: The ability of Staphylococcus aureus to evade killing by human neutrophils significantly contributes to disease progression. In this study, we characterize an influential role for the S. aureus SaeR/S 2-component gene regulatory system in suppressing monocyte production of tumor necrosis factor alpha (TNF-α) to subsequently influence human neutrophil priming.
Methods: Using flow cytometry and TNF-α specific enzyme-linked immunosorbent assays we identify the primary cellular source of TNF-α in human blood and in purified peripheral blood mononuclear cells (PBMCs) during interaction with USA300 and an isogenic saeR/S deletion mutant (USA300∆saeR/S). Assays with conditioned media from USA300 and USA300∆saeR/S exposed PBMCs were used to investigate priming on neutrophil bactericidal activity.
Results: TNF-α production from monocytes was significantly reduced following challenge with USA300 compared to USA300∆saeR/S. We observed that priming of neutrophils using conditioned medium from peripheral blood mononuclear cells stimulated with USA300∆saeR/S significantly increased neutrophil bactericidal activity against USA300 relative to unprimed neutrophils and neutrophils primed with USA300 conditioned medium. The increased neutrophil bactericidal activity was associated with enhanced reactive oxygen species production that was significantly influenced by elevated TNF-α concentrations. Conclusions: Our findings identify an immune evasion strategy used by S. aureus to impede neutrophil priming and subsequent bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29272502      PMCID: PMC7191620          DOI: 10.1093/infdis/jix652

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  Role and regulation of the superoxide dismutases of Staphylococcus aureus.

Authors:  Michail H Karavolos; Malcolm J Horsburgh; Eileen Ingham; Simon J Foster
Journal:  Microbiology       Date:  2003-10       Impact factor: 2.777

2.  Staphylococcus aureus Inhibits Neutrophil-derived IL-8 to Promote Cell Death.

Authors:  Oliwia W Zurek; Kyler B Pallister; Jovanka M Voyich
Journal:  J Infect Dis       Date:  2015-02-26       Impact factor: 5.226

3.  Differential regulation of staphylococcal virulence by the sensor kinase SaeS in response to neutrophil-derived stimuli.

Authors:  Caralyn E Flack; Oliwia W Zurek; Delisha D Meishery; Kyler B Pallister; Cheryl L Malone; Alexander R Horswill; Jovanka M Voyich
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-29       Impact factor: 11.205

4.  SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis.

Authors:  Tyler K Nygaard; Kyler B Pallister; Peter Ruzevich; Shannon Griffith; Cuong Vuong; Jovanka M Voyich
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

5.  Killing of Staphylococcus aureus by tumor necrosis factor-alpha-activated neutrophils. The role of serum opsonins, integrin receptors, respiratory burst, and degranulation.

Authors:  A Ferrante; A J Martin; E J Bates; D H Goh; D P Harvey; D Parsons; D A Rathjen; G Russ; J M Dayer
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

6.  Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection.

Authors:  Christopher P Montgomery; Susan Boyle-Vavra; Robert S Daum
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

7.  Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis.

Authors:  Y Zhang; B F Ramos; B A Jakschik
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

8.  Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.

Authors:  M S Bajaj; R R Kew; R O Webster; T M Hyers
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

9.  The SaeR/S gene regulatory system induces a pro-inflammatory cytokine response during Staphylococcus aureus infection.

Authors:  Robert L Watkins; Kyler B Pallister; Jovanka M Voyich
Journal:  PLoS One       Date:  2011-05-13       Impact factor: 3.240

10.  Inability to sustain intraphagolysosomal killing of Staphylococcus aureus predisposes to bacterial persistence in macrophages.

Authors:  Jamil Jubrail; Paul Morris; Martin A Bewley; Simon Stoneham; Simon A Johnston; Simon J Foster; Andrew A Peden; Robert C Read; Helen M Marriott; David H Dockrell
Journal:  Cell Microbiol       Date:  2015-09-02       Impact factor: 3.715

View more
  3 in total

1.  Direct Microscopic Observation of Human Neutrophil-Staphylococcus aureus Interaction In Vitro Suggests a Potential Mechanism for Initiation of Biofilm Infection on an Implanted Medical Device.

Authors:  Niranjan Ghimire; Brian A Pettygrove; Kyler B Pallister; James Stangeland; Shelby Stanhope; Isaac Klapper; Jovanka M Voyich; Philip S Stewart
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

2.  Staphylococcus aureus induces a muted host response in human blood that blunts the recruitment of neutrophils.

Authors:  Erin E Zwack; Ze Chen; Joseph C Devlin; Zhi Li; Xuhui Zheng; Ada Weinstock; Keenan A Lacey; Edward A Fisher; David Fenyö; Kelly V Ruggles; P'ng Loke; Victor J Torres
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-26       Impact factor: 12.779

3.  The LiaFSR Transcriptome Reveals an Interconnected Regulatory Network in Group A Streptococcus.

Authors:  Misu A Sanson; Luis Alberto Vega; Brittany Shah; Shrijana Regmi; M Belen Cubria; Nicola Horstmann; Samuel A Shelburne; Anthony R Flores
Journal:  Infect Immun       Date:  2021-08-09       Impact factor: 3.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.